[Ip-health] PhRMA’s 2018 Special 301 Submission targets Australia, Canada, S. Korea, Japan & others over pricing, reimbursement policies

Andrew Goldman andrew.goldman at keionline.org
Mon Feb 12 12:01:12 PST 2018


I posted a short blog on PhRMA's comments in its 301 submission regarding
pricing and reimbursement policies of Canada, Korea, Japan and Australia,
here: https://www.keionline.org/25533

Andy

--
Andrew S. Goldman
Counsel, Policy and Legal Affairs
Knowledge Ecology International
andrew.goldman at keionline.org // www.twitter.com/ASG_KEI
tel.: +1.202.332.2670 <(202)%20332-2670>
www.keionline.org


More information about the Ip-health mailing list